Attention Deficit Hyperactivity Disorder Market Size, Share & Trends Analysis Report By Drug Type (Stimulants, Non-stimulants), By Demographics (Children, Adults), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030
- Report ID: GVR-2-68038-795-7
- Number of Pages: 114
- Format: Electronic (PDF)
- Historical Range: 2018 - 2021
- Industry: Healthcare
Market Segmentation
- Attention Deficit Hyperactivity Disorder Drug Type Outlook (Revenue, USD Million, 2018 - 2030)
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- Attention Deficit Hyperactivity Disorder Demographics Outlook (Revenue, USD Million, 2018 - 2030)
- Children (2 to 17 years of age)
- Adults
- Attention Deficit Hyperactivity Disorder Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Retail Pharmacy
- Hospital Pharmacy
- Attention Deficit Hyperactivity Disorder Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- North America ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- North America ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- U.S.
- U.S. ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- U.S. ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- U.S. ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- U.S. ADHD Market, By Drug Type
- Canada
- Canada ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- Canada ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- Canada ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Canada ADHD Market, By Drug Type
- North America ADHD Market, By Drug Type
- Europe
- Europe ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- Europe ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- Europe ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Germany
- Germany ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- Germany ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- Germany ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Germany ADHD Market, By Drug Type
- U.K.
- U.K. ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- U.K. ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- U.K. ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- U.K. ADHD Market, By Drug Type
- France
- France ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- France ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- France ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- France ADHD Market, By Drug Type
- Italy
- Italy ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- Italy ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- Italy ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Italy ADHD Market, By Drug Type
- Spain
- Spain ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- Spain ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- Spain ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Spain ADHD Market, By Drug Type
- Europe ADHD Market, By Drug Type
- Asia Pacific
- Asia Pacific ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- Asia Pacific ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- Asia Pacific ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- China
- China ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- China ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- China ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- China ADHD Market, By Drug Type
- India
- India ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- India ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- India ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- India ADHD Market, By Drug Type
- Japan
- Japan ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- Japan ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- Japan ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Japan ADHD Market, By Drug Type
- Australia
- Australia ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- Australia ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- Australia ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Australia ADHD Market, By Drug Type
- South Korea
- South Korea ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- South Korea ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- South Korea ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- South Korea ADHD Market, By Drug Type
- Asia Pacific ADHD Market, By Drug Type
- Latin America
- Latin America ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- Latin America ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- Latin America ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Brazil
- Brazil ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- Brazil ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- Brazil ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Brazil ADHD Market, By Drug Type
- Mexico
- Mexico ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- Mexico ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- Mexico ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Mexico ADHD Market, By Drug Type
- Argentina
- Argentina ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- Argentina ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- Argentina ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Argentina ADHD Market, By Drug Type
- Latin America ADHD Market, By Drug Type
- Middle East & Africa
- Middle East & Africa ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- Middle East & Africa ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- Middle East & Africa ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- South Africa
- South Africa ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- South Africa ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- South Africa ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- South Africa ADHD Market, By Drug Type
- Saudi Arabia
- Saudi Arabia ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- Saudi Arabia ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- Saudi Arabia ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Saudi Arabia ADHD Market, By Drug Type
- UAE
- UAE ADHD Market, By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
- Stimulants
- UAE ADHD Market, By Demographics
- Children (2 to 17 years of age)
- Adults
- UAE ADHD Market, By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- UAE ADHD Market, By Drug Type
- Middle East & Africa ADHD Market, By Drug Type
- North America
Report Content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s Five Forces analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
